Business Description
Founded in Seoul, South Korea in 2016, 3billion Inc. uses advanced data science and genetic analysis to help identify new treatments for rare diseases. The company works to pinpoint potential drug targets, develop drug candidates, and evaluate their safety profiles. It also offers testing services to help diagnose patients who may be living with rare genetic conditions.
